These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28263832)

  • 1. Amorphous is not always better-A dissolution study on solid state forms of carbamazepine.
    Jensen LG; Skautrup FB; Müllertz A; Abrahamsson B; Rades T; Priemel PA
    Int J Pharm; 2017 Apr; 522(1-2):74-79. PubMed ID: 28263832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
    Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supersaturation of zafirlukast in fasted and fed state intestinal media with and without precipitation inhibitors.
    Madsen CM; Boyd B; Rades T; Müllertz A
    Eur J Pharm Sci; 2016 Aug; 91():31-9. PubMed ID: 27260089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer incorporation method affects the physical stability of amorphous indomethacin in aqueous suspension.
    Surwase SA; Itkonen L; Aaltonen J; Saville D; Rades T; Peltonen L; Strachan CJ
    Eur J Pharm Biopharm; 2015 Oct; 96():32-43. PubMed ID: 26092472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of induction methods for supersaturation: Amorphous dissolution versus solvent shift.
    Plum J; Bavnhøj CG; Eliasen JN; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2020 Jul; 152():35-43. PubMed ID: 32376371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tablet formulation and subsequent film coating on the supersaturated dissolution behavior of amorphous solid dispersions.
    Sakai T; Hirai D; Kimura SI; Iwao Y; Itai S
    Int J Pharm; 2018 Apr; 540(1-2):171-177. PubMed ID: 29447848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism-based selection of stabilization strategy for amorphous formulations: Insights into crystallization pathways.
    Edueng K; Mahlin D; Larsson P; Bergström CAS
    J Control Release; 2017 Jun; 256():193-202. PubMed ID: 28412224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
    Jackson MJ; Kestur US; Hussain MA; Taylor LS
    Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wetting Kinetics: an Alternative Approach Towards Understanding the Enhanced Dissolution Rate for Amorphous Solid Dispersion of a Poorly Soluble Drug.
    Verma S; Rudraraju VS
    AAPS PharmSciTech; 2015 Oct; 16(5):1079-90. PubMed ID: 25672820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H; Fussnegger B; Bodmeier R
    Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissolution performance of binary amorphous drug combinations--Impact of a second drug on the maximum achievable supersaturation.
    Trasi NS; Taylor LS
    Int J Pharm; 2015 Dec; 496(2):282-90. PubMed ID: 26456250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theoretical evaluation of supersaturation of amorphous solid dispersion formulations with different drug/polymer combinations using mathematical modeling.
    Hirai D; Tsunematsu H; Kimura SI; Itai S; Fukami T; Iwao Y
    Int J Pharm; 2022 Sep; 625():122110. PubMed ID: 35970282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Eudragit EPO and hydroxypropyl methylcellulose on drug release rate, supersaturation, precipitation outcome and redissolution rate of indomethacin amorphous solid dispersions.
    Xie T; Gao W; Taylor LS
    Int J Pharm; 2017 Oct; 531(1):313-323. PubMed ID: 28844901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Influence of Various Polymers on Dissolution and Phase Behavior of Carbamazepine-Succinic Acid Cocrystal in Matrix Tablets.
    Ullah M; Ullah H; Murtaza G; Mahmood Q; Hussain I
    Biomed Res Int; 2015; 2015():870656. PubMed ID: 26380301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the generation and maintenance of supersaturation during the dissolution of amorphous solid dispersions using modulated DSC and
    Baghel S; Cathcart H; O'Reilly NJ
    Int J Pharm; 2018 Jan; 536(1):414-425. PubMed ID: 29183857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissolution and precipitation behavior of amorphous solid dispersions.
    Alonzo DE; Gao Y; Zhou D; Mo H; Zhang GGZ; Taylor LS
    J Pharm Sci; 2011 Aug; 100(8):3316-3331. PubMed ID: 21607951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the Effects of a Polymer on the Surface Dissolution of Pharmaceutical Cocrystals Using Combined Experimental and Molecular Dynamics Simulation Approaches.
    Kirubakaran P; Wang K; Rosbottom I; Cross RBM; Li M
    Mol Pharm; 2020 Feb; 17(2):517-529. PubMed ID: 31887053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of crystal nucleation and growth by water-soluble polymers and its impact on the supersaturation profiles of amorphous drugs.
    Ozaki S; Kushida I; Yamashita T; Hasebe T; Shirai O; Kano K
    J Pharm Sci; 2013 Jul; 102(7):2273-81. PubMed ID: 23658029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
    Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
    Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.